Devices for detection and therapy of atheromatous plaque

Details Devices for detection and therapy of atheromatous plaque Devices for detection and therapy of atheromatous plaque

2002-08-09

2010-10-05

Le, Long V (Department: 3768)

Surgery

Diagnostic testing

Detecting nuclear, electromagnetic, or ultrasonic radiation

C600S431000, C623S001420, C623S001110

Reexamination Certificate

active

07809428

ABSTRACT:
The present invention relates to devices for detection of active atheromatous plaque and/or thin-capped fibro-atheroma (“vulnerable plaque”) using selectively targeted radiolabeled compositions, such as beta-emitting compositions.

REFERENCES:
patent: 4141347 (1979-02-01), Green et al.
patent: 4512762 (1985-04-01), Spears
patent: 4577636 (1986-03-01), Spears
patent: 4995396 (1991-02-01), Inaba et al.
patent: 5008546 (1991-04-01), Mazziotta et al.
patent: 5046501 (1991-09-01), Crilly
patent: 5104392 (1992-04-01), Kittrell et al.
patent: 5116864 (1992-05-01), March et al.
patent: 5169395 (1992-12-01), Narciso, Jr.
patent: 5197470 (1993-03-01), Helfer et al.
patent: 5298018 (1994-03-01), Narciso, Jr.
patent: 5308861 (1994-05-01), Aizawa et al.
patent: 5364612 (1994-11-01), Goldenberg
patent: 5409710 (1995-04-01), Leonard
patent: 5419323 (1995-05-01), Kittrell et al.
patent: 5422362 (1995-06-01), Vincent et al.
patent: 5424073 (1995-06-01), Rahman et al.
patent: 5484803 (1996-01-01), Richter
patent: 5568532 (1996-10-01), Majewski et al.
patent: 5639600 (1997-06-01), McGrath et al.
patent: 5693043 (1997-12-01), Kittrell et al.
patent: 5716595 (1998-02-01), Goldenberg
patent: 5736563 (1998-04-01), Richter
patent: 5744805 (1998-04-01), Raylman et al.
patent: 5773417 (1998-06-01), Bonaventura
patent: 5776966 (1998-07-01), North
patent: 5789433 (1998-08-01), Chan et al.
patent: 5798349 (1998-08-01), Levy et al.
patent: 5807881 (1998-09-01), Leong et al.
patent: 5811814 (1998-09-01), Leone et al.
patent: 5829448 (1998-11-01), Fisher et al.
patent: 5834503 (1998-11-01), Kelly et al.
patent: 5864141 (1999-01-01), Majewski et al.
patent: 5882335 (1999-03-01), Leone et al.
patent: 5919135 (1999-07-01), Lemelson
patent: 5924997 (1999-07-01), Campbell
patent: 5932879 (1999-08-01), Raylman et al.
patent: 5952329 (1999-09-01), Cincotta et al.
patent: 5976496 (1999-11-01), Dean et al.
patent: 6033436 (2000-03-01), Steinke et al.
patent: 6042603 (2000-03-01), Fisher et al.
patent: 6054449 (2000-04-01), Robinson et al.
patent: 6076009 (2000-06-01), Raylman et al.
patent: 6180402 (2001-01-01), Granville et al.
patent: 6211349 (2001-04-01), Dale et al.
patent: 6238348 (2001-05-01), Crowley et al.
patent: 6246901 (2001-06-01), Benaron
patent: 6286514 (2001-09-01), Lemelson
patent: 6295680 (2001-10-01), Wahl et al.
patent: 6547812 (2003-04-01), Hu
patent: 6716410 (2004-04-01), Witztum et al.
patent: 6764501 (2004-07-01), Ganz
patent: 6782289 (2004-08-01), Strauss
patent: 6816743 (2004-11-01), Moreno et al.
patent: 6869590 (2005-03-01), Edwards et al.
patent: 6894161 (2005-05-01), Desjardins et al.
patent: 6906050 (2005-06-01), Robinson
patent: 7373197 (2008-05-01), Daighighian et al.
patent: 2002/0115649 (2002-08-01), Woodburn et al.
patent: 2002/0168317 (2002-11-01), Daighighian et al.
patent: 2003/0138411 (2003-07-01), Greaves
patent: 2003/0152513 (2003-08-01), Blankenberg et al.
patent: 2003/0235531 (2003-12-01), Adair
patent: 2004/0057900 (2004-03-01), Edwards et al.
patent: 2004/0086495 (2004-05-01), Kriegelstein et al.
patent: 2005/0244336 (2005-11-01), Low
patent: 2006/0073100 (2006-04-01), Fischman et al.
patent: 2007/0258906 (2007-11-01), Fischman et al.
patent: 2007/0264194 (2007-11-01), Liu et al.
patent: 0352076 (1990-01-01), None
patent: 84/02069 (1984-06-01), None
patent: WO 90/05748 (1990-05-01), None
patent: 95/00605 (1995-01-01), None
patent: 99/12579 (1999-03-01), None
patent: WO 01/32070 (2001-05-01), None
patent: 03/003975 (2003-01-01), None
patent: WO 03/020765 (2003-03-01), None
patent: WO 03/077723 (2003-09-01), None
Akhlynina, T., et al., “Insulin-mediated Intracellular Targeting Enhances the Photodynamic Activity of Chlorin e6,”Cancer Research, 55: 1014-1019, 1995.
Araki, N., et al., “Macrophage Scavenger Receptor Mediates the Endocytic Uptake and Degradation of Advanced Glycation End Products of the Maillard Reaction,”Eur. J. Biochem., 230: 408-415, 1995.
Arbustini, E., et al., “Comparison of Coronary Lesions Obtained By Directional Coronary Atherectomy in Unstable Angina, Stable Angina, and Restenosis After Either Atherectomy or Angioplasty,”The American Journal of Cardiology, 75: 675-682, 1995.
Arroyo, L.H., et al., “Mechanisms of Plaque Rupture: Mechanical and Biologic Interactions,”Cardiovascular Research, 41: 369-375, 1999.
Bachor, R., et al., “Photosensitized Destruction of Human Bladder Carcinoma Cells Treated With Chlorin e6-conjugated Microspheres,”Proc. Natl. Acad. Sci. USA, 88: 1580-1584, 1991.
Ball, D.J., et al., “The Induction of Apoptosis by a Positively Charged Methylene Blue Derivative,”Journal of Photochemistry and Photobiology B: Biology, 42: 159-163, 1998.
Basu, S., “Enhanced Intracellular Delivery of Doxorubicin by Scavenger Receptor-Mediated Endocytosis for Preferential Killing of Histiocytic Lymphoma Cells in Culture,”FEBS Letters, 342: 249-254, 1994.
Basu, S. K., “Receptor-Mediated Endocytosis of Macromolecular Conjugates in Selective Drug Delivery,”Biochemical Pharmacology, 40(9): 1941-1946, 1990.
Casscells, W., et al., “Thermal Detection of Cellular Infiltrates in Living Atherosclerotic Plaques: Possible Implications for Plaque Rupture and Thrombosis,”Lancet, 347: 1447-1451, 1996.
Del Governatore, M., et al., “Targeted Photodestruction of Human Colon Cancer Cells Using Charged 17.1A Chlorin e6Immunoconjugates,”British Journal of Cancer, 82(1): 56-64, 2000.
De Smith, P.C., “LDL-Mediated Drug Targeting,”Critical Rev. In Ther. Drug Carrier Syst., 7(2): 99-120, 1990.
Dougherty, T.J., et al., “Photodynamic Theory,”Journal of the National Cancer Institute, 90(12): 889-905, 1998.
Dvorak, H.F., et al., “Identification and Characterization of the Blood Vessels of Solid Tumors that are Leaky to Circulating Macromolecules,”American Journal of Pathology, 133(1): 95-109, 1988.
Eisenbrand, G., et al., “Modes of Action and Perspectives in the Use of Hormone Receptor Affine Carrier Molecules,”Acta Oncologica, 28: 203-211, 1989.
Falk, E., “Morphologic Features of Unstable Atherothrombotic Plaques Underlying Acute Coronary Syndromes,”The American Journal Of Cardiology, 63: 114E-120E,1989.
Farb, A., et al., “Sudden Coronary Death: Frequency of Active Coronary Lesions, Inactive Coronary Lesions, and Myocardial Infarction,”Circulation, 92(7): 1701-1709, 1995.
Ferrario, A., et al., “Systemic Toxicity in Mice Induced by Localized Porphyrin Photodynamic Therapy,”Cancer Research, 50: 539-543, 1990.
Gijsens, A., et al., “Photocytotoxic action of EGF-PVA-Sn(IV)chlorin e6and EGF-dextran-Sn(IV)chlorin e6in internalizable conjugates on A431 cells,”Int. J. Oncol., 13: 1171-1177, 1998.
Gomer, C.J., “Preclinical Examination of First and Second Generation Photosensitizers Used in Photodynamic Therapy,”Photochemistry and Photobiology, 54(6): 1093-1107, 1991.
Gutstein, D., et al., “Pathophysiology and Clinical Significance of Atherosclerotic Plaque Rupture,”Cardiovascular Research, 41: 323-333, 1999.
Haberland, M.E., et al., “Malondialdehyde Modification of Lipoprotein(a) Produces Avid Uptake by Human Monocyte-Macrophages,”The Journal of Biological Chemistry, 267(6): 4143-4151,1992.
Haberland, M.E., et al., “Scavenger Receptor-Mediated Recognition of Maleyl Bovine Plasma Albumin and the Demaleylated Protein in Human Monocyte Macrophages,”Proc. Natl. Acad. Sci. USA, 82: 2693-2697, 1985.
Haberland, M.E., et al., “Specificity of Receptor-Mediated Recognition of Malondialdehyde Modified Low Density Lipoproteins,”Proc. Natl. Acad. Sci. USA, 79: 1712-1716, 1982.
Hamblin, M.R., et al., “Biodistribution of Charged 17.1A Photoimmunoconjugates in a Murine Model of Hepatic Metastasis of Colorectal Cancer,”British Journal of Cancer, 83(11): 1544-1551, 2000.
Hamblin, M.R., et al., “In Vivo Fluorescence Imaging of the Transport of Charged Chlorin e6C

Affiliated with

Also associated with

Rating

Devices for detection and therapy of atheromatous plaque does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Devices for detection and therapy of atheromatous plaque, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Devices for detection and therapy of atheromatous plaque will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4239829